These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20875051)

  • 21. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
    Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism.
    Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z
    Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
    Lamensdorf I; Porat S; Simantov R; Finberg JP
    Br J Pharmacol; 1999 Feb; 126(4):997-1002. PubMed ID: 10193780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
    Hadlock GC; Baucum AJ; King JL; Horner KA; Cook GA; Gibb JW; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Apr; 329(1):169-74. PubMed ID: 19141713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral Changes and Neuronal Damage in Rhesus Monkeys after 10 Weeks of Ketamine Administration Involve Prefrontal Cortex Dopamine D2 Receptor and Dopamine Transporter.
    Sun Z; Ma Y; Xie L; Huang J; Duan S; Guo R; Xie Y; Lv J; Lin Z; Ma S
    Neuroscience; 2019 Sep; 415():97-106. PubMed ID: 31330230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine.
    Nikolaus S; Beu M; Angelica De Souza Silva M; Huston JP; Hautzel H; Antke C; Müller HW
    Synapse; 2016 Sep; 70(9):369-77. PubMed ID: 27164322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubes.
    Folkmann JK; Risom L; Jacobsen NR; Wallin H; Loft S; Møller P
    Environ Health Perspect; 2009 May; 117(5):703-8. PubMed ID: 19479010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.
    Hadlock GC; Chu PW; Walters ET; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2010 Oct; 335(1):207-12. PubMed ID: 20622144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine modulates allosteric D
    Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
    Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
    Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
    J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties.
    Li X; Qi J; Yamaguchi T; Wang HL; Morales M
    Brain Struct Funct; 2013 Sep; 218(5):1159-76. PubMed ID: 22926514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes.
    Lin YT; Liu W; He Y; Wu YL; Chen WN; Lin XJ; Lin X
    Cell Physiol Biochem; 2018; 51(1):80-96. PubMed ID: 30448843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells.
    Mercuri NB; Scarponi M; Bonci A; Siniscalchi A; Bernardi G
    J Neurosci; 1997 Apr; 17(7):2267-72. PubMed ID: 9065488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
    Wang D; Wong HK; Zhang L; McAlonan GM; Wang XM; Sze SC; Feng YB; Zhang ZJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):332-8. PubMed ID: 22796279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
    Lin CH; Huang JY; Ching CH; Chuang JI
    J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal deprivation-caused behavioral abnormalities in adult rats relate to a non-methylation-regulated D2 receptor levels in the nucleus accumbens.
    Zhu X; Li T; Peng S; Ma X; Chen X; Zhang X
    Behav Brain Res; 2010 Jun; 209(2):281-8. PubMed ID: 20144661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.
    Bertolino A; Fazio L; Di Giorgio A; Blasi G; Romano R; Taurisano P; Caforio G; Sinibaldi L; Ursini G; Popolizio T; Tirotta E; Papp A; Dallapiccola B; Borrelli E; Sadee W
    J Neurosci; 2009 Jan; 29(4):1224-34. PubMed ID: 19176830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter trafficking is regulated by neutral sphingomyelinase 2/ceramide kinase.
    Won JH; Kim SK; Shin IC; Ha HC; Jang JM; Back MJ; Kim DK
    Cell Signal; 2018 Apr; 44():171-187. PubMed ID: 29329781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3.
    Saroja SR; Aher YD; Kalaba P; Aher NY; Zehl M; Korz V; Subramaniyan S; Miklosi AG; Zanon L; Neuhaus W; Höger H; Langer T; Urban E; Leban J; Lubec G
    Behav Brain Res; 2016 Oct; 312():127-37. PubMed ID: 27288589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.